New antipsychotic medications in the last decade
M Pahwa, A Sleem, OH Elsayed, ME Good… - Current Psychiatry …, 2021 - Springer
Abstract Purpose of Review Over the last ten years, the treatment of psychosis has seen a
near explosion of creative development in both novel agents and new delivery modalities …
near explosion of creative development in both novel agents and new delivery modalities …
[HTML][HTML] Clinical Outcome Assessment Instruments in Schizophrenia: A Scoping Literature Review with a Focus on the Potential of Patient-reported Outcomes
L Citrome, MA Mychaskiw, A Cortez… - Innovations in Clinical …, 2023 - ncbi.nlm.nih.gov
Objective The complexity inherent in the treatment of schizophrenia results in a multitude of
outcome assessments being employed when conducting clinical trials. Subjective outcome …
outcome assessments being employed when conducting clinical trials. Subjective outcome …
Conventional and retrospective change in health-related quality of life of trauma patients: an explorative observational follow-up study
Background Within trauma care measurement of changes in health-related quality of life
(HRQL) is used in understanding patterns of recovery over time. However, conventionally …
(HRQL) is used in understanding patterns of recovery over time. However, conventionally …
An overview of the currently available and emerging long-acting formulations of risperidone for schizophrenia and bipolar disorder
J Faden, C Ramirez, V Martinez… - Expert Review of …, 2024 - Taylor & Francis
Introduction Long-acting injectable (LAI) antipsychotic medications can help improve
treatment adherence in patients with schizophrenia and bipolar disorder. Despite this, they …
treatment adherence in patients with schizophrenia and bipolar disorder. Despite this, they …
Newer formulations of risperidone: role in the management of psychotic disorders
I Clark, D Taylor - CNS drugs, 2020 - Springer
Antipsychotic long-acting injections improve relapse prevention in psychotic disorders.
Three new risperidone formulations have been developed that offer advantages over …
Three new risperidone formulations have been developed that offer advantages over …
An Open-Label Study to Assess Monthly Risperidone Injections (180 mg) Following Switch from Daily Oral Risperidone (6 mg) in Stable Schizophrenic Patients
DP Walling, SN Shinde, JM Pogoda, J Kharidia… - Clinical Drug …, 2024 - Springer
Abstract Background and Objective Long-acting injectable antipsychotics have shown
benefits over oral medications with reduced hospitalization rates and improved health …
benefits over oral medications with reduced hospitalization rates and improved health …
Once-monthly subcutaneously administered risperidone in the treatment of schizophrenia: patient considerations
LV Tchobaniouk, EE McAllister, DL Bishop… - Patient preference …, 2019 - Taylor & Francis
Adherence to antipsychotic medications is a major challenge in schizophrenia. Long-acting
injectable antipsychotics have been shown to offer advantages over oral formulations. A …
injectable antipsychotics have been shown to offer advantages over oral formulations. A …
Процена Утицаја Антипсихотика На Коштани Метаболизам и Карактеристике Телесног Састава Болесника Са Схизофренијом
АП Корићанац - 2023 - search.proquest.com
Процена утицаја антипсихотика на коштани метаболизам и карактеристи Page 1
УНИВЕРЗИТЕТ У КРАГУЈЕВЦУ Факултет медицинских наука Александра П …
УНИВЕРЗИТЕТ У КРАГУЈЕВЦУ Факултет медицинских наука Александра П …
Procena uticaja antipsihotika na koštani metabolizam i karakteristike telesnog sastava bolesnika sa shizofrenijom
AP Korićanac - Универзитет у Крагујевцу, 2023 - nardus.mpn.gov.rs
Uvod: Podaci iz literature pokazuju da terapija antipsihoticima može da utiče na koštani
metabolizam kod pacijenata sa shizofrenijom. Cilj: Naš cilj je bio da utvrdimo uticaj različitih …
metabolizam kod pacijenata sa shizofrenijom. Cilj: Naš cilj je bio da utvrdimo uticaj različitih …
[PDF][PDF] Risdiplam (Evrysdi)
R Team - Canadian Journal of Health Technologies, 2021 - canjhealthtechnol.ca
Risdiplam (Evrysdi) Page 1 November 2021 Volume 1 Issue 11 Clinical Review
Pharmacoeconomic Review CADTH Reimbursement Review Risdiplam (Evrysdi) Sponsor …
Pharmacoeconomic Review CADTH Reimbursement Review Risdiplam (Evrysdi) Sponsor …